A study by the Barcelona Institute for Global Health (ISGlobal) and the European & Developing Countries Clinical Trials Partnership (EDCTP) has found that preventive treatment with DHA-PPQ is a safe and effective method for women living with HIV to prevent malaria during pregnancy, even in low malaria transmission areas. The trial involved more than 600 pregnant women in Gabon and Mozambique. The findings could help protect an estimated one million pregnant women who annually suffer from a dual malaria and HIV infection.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
